459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hellmann, Matthew
  • Cho, Byoung
  • Juergens, Rosalyn
  • Cheng, Ying
  • Castro, Gilberto de
  • Erman, Mustafa
  • Bauman, Jessica
  • Takahashi, Toshiaki
  • Schwarzenberger, Paul
  • Zhang, Pingye
  • Catherine Pietanza, M
  • Yang, James Chih-Hsin

publication date

  • November 2021